• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Harry Büller - Articles and news items

Daiichi Sankyo logo
Daiichi Sankyo logo

Daiichi Sankyo completes enrolment in Hokusai-VTE

Industry news, News / 25 October 2012 / Daiichi Sankyo

Edoxaban is an investigational, once daily, novel oral factor Xa inhibitor…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +